gwpharm.com 訪問サイト

サーバーの場所

トップのURL解析

http://www.gwpharm.com/
http://www.gwpharm.com/GW%20Pharmaceuticals%20Commences%20Phase%201b2a%20Clinical%20Trial%20%20for%20the%20Treatment%20of%20Glioblastoma%20Multiforme%20GBM.aspx
http://www.gwpharm.com/GW%20Pharmaceuticals%20Announces%20Positive%20Phase%203%20Pivotal%20Trial%20Results%20for%20Epidiolex%20cannabidiol%20in%20the%20Treatment%20of%20Lennox-Gastaut%20Syndrome.aspx
http://www.gwpharm.com/GW%20Pharmaceuticals%20plc%20Announces%20US%20Patent%20Allowance%20for%20Use%20of%20Cannabinoids%20in%20Treating%20Glioma.aspx
http://ir.gwpharm.com/
http://www.gwpharm.com/GW%20Pharmaceuticals%20Announces%20Epidiolex%20Receives%20Fast%20Track%20Designation%20from%20FDA%20for%20the%20Treatment%20of%20Dravet%20Syndrome.aspx
http://www.gwpharm.com/FAQ.aspx
http://www.gwpharm.com/SPC.aspx
http://ir.gwpharm.com/events.cfm
http://www.gwpharm.com/GW%20Pharmaceuticals%20Announces%20Positive%20Proof%20of%20Concept%20Data%20in%20Schizophrenia.aspx
http://www.gwpharm.com/GW%20Pharmaceuticals%20Announces%20Positive%20Phase%203%20Pivotal%20Study%20Results%20for%20Epidiolex%20cannabidiol.aspx
http://www.gwpharm.com/GW%20Pharmaceuticals%20Initiates%20Phase%202%20Clinical%20Study%20of%20Cannabidivarin%20CBDV%20in%20Epilepsy.aspx
http://www.gwpharm.com/Results%20from%20GW%20Phase%20IIa%20Study%20Identify%20Promising%20New%20Oral%20Cannabinoid%20Anti-Diabetic%20Treatment.aspx
http://www.gwpharm.com/product-pipeline.aspx
http://www.gwpharm.com/Sativex.aspx
http://www.gwpharm.com/Epidiolex.aspx
http://www.gwpharm.com/about-us.aspx
http://www.gwpharm.com/media.aspx
http://www.gwpharm.com/management-team.aspx
http://www.gwpharm.com/GW%20and%20Bayer%20Announce%20Marketing%20Agreement%20on%20Pioneering%20New%20Cannabis-based%20Treatment.aspx

Whois

Domain Name: gwpharm.com
Registry Domain ID: 27875646_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.ascio.com
Registrar URL: http://www.ascio.com
Updated Date: 2016-04-29T22:42:30Z
Creation Date: 2000-05-26T10:20:11Z
Registrar Registration Expiration Date: 2017-05-26T14:20:11Z
Registrar: Ascio Technologies, Inc
Registrar IANA ID: 106
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +44.2070159370
Domain Status: clientTransferProhibited http://www.icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited http://www.icann.org/epp#clientUpdateProhibited
Domain Status: clientDeleteProhibited http://www.icann.org/epp#clientDeleteProhibited
For more information on Whois status codes, please visit https://icann.org/epp
Registry Registrant ID:
Registrant Name: Chris Smith
Registrant Organization: GW Pharma Ltd.
Registrant Street: Porton Down Science Park
Registrant City: Salisbury
Registrant State/Province: Wiltshire
Registrant Postal Code: SP4 0JQ
Registrant Country: GB
Registrant Phone: +44.1353616609
Registrant Phone Ext:
Registrant Fax:
Registrant Fax Ext:
Registrant Email: [email protected]
Registry Admin ID:
Admin Name: Chris Smith
Admin Organization: GW Pharma
Admin Street: Porton Down Science Park
Admin City: Salisbury
Admin State/Province: Wiltshire
Admin Postal Code: SP4 0JQ
Admin Country: GB
Admin Phone: +44.1353616609
Admin Phone Ext:
Admin Fax:
Admin Fax Ext:
Admin Email: [email protected]
Registry Tech ID:
Tech Name: NetNames Hostmaster
Tech Organization: Netnames Ltd
Tech Street: 3rd Floor Prospero House
Tech Street: 241 Borough High St.
Tech City: null
Tech State/Province: London
Tech Postal Code: SE1 1GA
Tech Country: GB
Tech Phone: +44.2070159370
Tech Phone Ext:
Tech Fax: +44.2070159375
Tech Fax Ext:
Tech Email: [email protected]
Name Server: ns1.netnames.net
Name Server: ns2.netnames.net
DNSSEC: unsigned
URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/
>>> Last update of WHOIS database: 2016-11-30T20:56:12 UTC <<<

The data in Ascio Technologies' WHOIS database is provided
by Ascio Technologies for information purposes only. By submitting
a WHOIS query, you agree that you will use this data only for lawful
purpose. In addition, you agree not to:
(a) use the data to allow, enable, or otherwise support any marketing
activities, regardless of the medium used. Such media include but are
not limited to e-mail, telephone, facsimile, postal mail, SMS, and
wireless alerts; or
(b) use the data to enable high volume, automated, electronic processes
that sendqueries or data to the systems of any Registry Operator or
ICANN-Accredited registrar, except as reasonably necessary to register
domain names or modify existing registrations.
(c) sell or redistribute the data except insofar as it has been
incorporated into a value-added product or service that does not permit
the extraction of a substantial portion of the bulk data from the value-added
product or service for use by other parties.
Ascio Technologies reserves the right to modify these terms at any time.
Ascio Technologies cannot guarantee the accuracy of the data provided.
By accessing and using Ascio Technologies WHOIS service, you agree to these terms.

  REGISTRAR ASCIO TECHNOLOGIES, INC. DANMARK - FILIAL AF ASCIO TECHNOLOGIES, INC. USA

  REFERRER http://www.ascio.com

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =gwpharm.com

  PORT 43

  SERVER whois.ascio.com

  ARGS gwpharm.com

  PORT 43

  TYPE domain

DOMAIN

  NAME gwpharm.com

NSERVER

  NS1.NETNAMES.NET 204.74.108.253

  NS2.NETNAMES.NET 185.83.102.12

STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited

  CHANGED 2016-04-29

  CREATED 2000-05-26

  EXPIRES 2017-05-26

  REGISTERED yes

HTTP Header 分析